The Study is designed to screen the patients with cardio-metabolic abnormalities. The final diagnosis and according treatment will be based on physicians interpretation and not the screening results of the device.
In case of registry, feedback mechanism is developed in which the cardiologist/electrophysiologist will check the screening results of device and physicians interpretation(blinded) and will provide their own interpretation, if discrepancy is found between the interpretations, the cardiologists can share the feedback to respective physicians.